Satellos Bioscience MSLE Cash Flow Statement (2024-2026)

NASDAQ MSLE
$8.60 -0.21 (-2.38%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Satellos Bioscience Quarterly Cash Flow Statement

Periods 6 quarters
Latest Jun 2026

Satellos Bioscience cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 6 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2024 Mar2025 Jun2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -22.73M6.14M-17.89M-24.86M-9.77M-11.72M
Depreciation and Depletion 0.00M0.00M0.00M
Share-based Compensation 0.64M0.83M0.73M0.92M
Asset Writedowns and Impairment -2.90M
Change in Working Capital 7.37M-19.57M-9.59M-8.03M
Change in Accured Expenses -0.89M0.07M0.42M1.32M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization 0.00M0.00M0.00M
Investing Activities
Capital Expenditures -0.00M
Change in Acquisitions & Divestments -43.88M-7.22M
Financing Activities
Change in Capital Stock
Net Preferred Shares Issued and Repurchased 4.65M
Net Equity Issued and Repurchased 0.00M1.39M47.25M-47.21M
Misc.
Exchange Rate Effect 0.00M-0.39M-0.09M0.28M
Change in Cash -7.36M5.50M8.89M-11.30M
Beginning Cash Balance 40.07M9.80M
Free Cash Flow 0.00M

Satellos Bioscience Cash Flow Statement API

Pull Satellos Bioscience's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MSLE&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY